PF-06663195

PF-06663195 is a β-secretase (BACE1) inhibitor, with BACE1 CFA and BACE1 WCA IC50 values of 53 and 15 nM, respectively. PF-06663195 can be used for Alzheimer's disease research[1].

Product Specifications

CAS Number

[1621585-22-5]

UNSPSC

12352005

Hazard Statement

H315-H319-H335

Target

Beta-secretase

Related Pathways

Neuronal Signaling

Field of Research

Neurological Disease

Smiles

FC[C@@H]1[C@@]2([H])[C@](N=C(S1)N)(C3=C(C=C(C=C3)F)F)CO[C@@H](C4=CC(C)=NO4)C2

Molecular Formula

C18H18F3N3O2S

Molecular Weight

397.41

Precautions

P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P362+P364-P403+P233-P405-P501

References & Citations

[1]Michael A Brodney, et al. Utilizing structures of CYP2D6 and BACE1 complexes to reduce risk of drug-drug interactions with a novel series of centrally efficacious BACE1 inhibitors. J Med Chem. 2015 Apr 9;58 (7) :3223-52.